Literature DB >> 23103827

Pro-apoptotic effect of anti-β1-adrenergic receptor antibodies in periodontitis patients.

Silvia Reina1, Sabrina Ganzinelli, Leonor Sterin-Borda, Enri Borda.   

Abstract

An anti-β(1)-adrenergic antibody from the sera of periodontitis patients (anti-β(1)-AR IgG) against the second extracellular loop of the human β(1)-adrenoceptor (β(1)-AR) has been shown to cause rat atria apoptosis. The anti-β(1)-AR IgG binds and activates atria β(1)-AR, increasing the intracellular calcium concentration, which, in turn, activates caspases-3, -8, and -9. The β(1)-AR and the post-receptor activation of calcium/calmodulin (CaM) lead to increased inducible nitric oxide synthase (iNOS) activity, with an increase in cyclic GMP (cGMP) accumulation as well as increased JNK phosphorylation and cyclic AMP (cAMP) production. We also observed an apoptotic effect of anti-β(1)-AR IgG, with increased generation of PGE(2). Comparatively, xamoterol, an authentic β(1)-AR agonist, mimicked the autoantibody effect on rat atria β(1)-AR apoptosis. Our results suggest that autoantibodies from the sera of periodontitis patients bind and interact with rat atria β(1)-AR, provoking apoptosis. This implicates a series of modulatory cardiac signaling events that could alter normal heart function and may occur with chronic stimulation of the atria β(1)-AR, which could lead to heart failure. These results suggest an important link between periodontitis and cardiovascular disease.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23103827     DOI: 10.1016/j.intimp.2012.10.011

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  6 in total

1.  A Periodontal pathogen Porphyromonas gingivalis deteriorates Isoproterenol-Induced myocardial remodeling in mice.

Authors:  Hiroki Sato; Jun-Ichi Suzuki; Norio Aoyama; Ryo Watanabe; Makoto Kaneko; Yuka Shiheido; Asuka Yoshida; Kouji Wakayama; Hidetoshi Kumagai; Yuichi Ikeda; Hiroshi Akazawa; Issei Komuro; Mitsuaki Isobe; Yuichi Izumi
Journal:  Hypertens Res       Date:  2016-09-08       Impact factor: 3.872

2.  Monoclonal anti-β1-adrenergic receptor antibodies activate G protein signaling in the absence of β-arrestin recruitment.

Authors:  Catherine J Hutchings; Gabriella Cseke; Greg Osborne; Jeanette Woolard; Andrei Zhukov; Markus Koglin; Ali Jazayeri; Jahnavi Pandya-Pathak; Christopher J Langmead; Stephen J Hill; Malcolm Weir; Fiona H Marshall
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

Review 3.  Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.

Authors:  Gerd Wallukat; Ingolf Schimke
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

4.  Diagnostic and prognostic value of autoantibodies against β1-adrenoreceptors in patients with heart failure following acute myocardial infarction: A 5-year prospective study.

Authors:  Xin Wang; Mengmeng Han; Shan He; Yuan Zhang; Xiaorong Xu; Yuxing Wang; Caijing Dang; Juan Zhang; Hua Wang; Mulei Chen; Jiamei Liu; Dongyan Hou; Wenshu Zhao; Lin Xu; Lin Zhang
Journal:  Exp Ther Med       Date:  2019-12-16       Impact factor: 2.447

5.  Decreased autophagy induced by β1-adrenoceptor autoantibodies contributes to cardiomyocyte apoptosis.

Authors:  Li Wang; Yang Li; Na Ning; Jin Wang; Zi Yan; Suli Zhang; Xiangying Jiao; Xiaohui Wang; Huirong Liu
Journal:  Cell Death Dis       Date:  2018-03-14       Impact factor: 8.469

6.  Autoantibodies against M5-muscarinic and beta1-adrenergic receptors in periodontitis patients.

Authors:  Isabel Scherbaum; Harald Heidecke; Kübra Bunte; Ulrike Peters; Thomas Beikler; Fritz Boege
Journal:  Aging (Albany NY)       Date:  2020-08-28       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.